Circulating interleukin-6 levels and cardiovascular and all-cause mortality in the elderly population: A meta-analysis.

[1]  B. Vaes,et al.  Interleukin-6 as a first-rated serum inflammatory marker to predict mortality and hospitalization in the oldest old: A regression and CART approach in the BELFRAIL study , 2015, Experimental Gerontology.

[2]  P. Whincup,et al.  Associations Between Fibrin D-Dimer, Markers of Inflammation, Incident Self-Reported Mobility Limitation, and All-Cause Mortality in Older Men , 2014, Journal of the American Geriatrics Society.

[3]  M. Reynolds,et al.  Influence of sex steroids on inflammation and bone metabolism. , 2014, Periodontology 2000.

[4]  M. Cesari,et al.  Proinflammatory cytokines, aging, and age-related diseases. , 2013, Journal of the American Medical Directors Association.

[5]  Wei Zhang,et al.  Prognostic role of C-reactive protein and interleukin-6 in dialysis patients: a systematic review and meta-analysis. , 2013, Journal of nephrology.

[6]  D. Brenner,et al.  Association between Serum Interleukin-6 Concentrations and Mortality in Older Adults: The Rancho Bernardo Study , 2012, PloS one.

[7]  M. Pahor,et al.  Interleukin‐6, C‐Reactive Protein, and Tumor Necrosis Factor‐Alpha as Predictors of Mortality in Frail, Community‐Living Elderly Individuals , 2011, Journal of the American Geriatrics Society.

[8]  A. Newman,et al.  Inflammatory markers in population studies of aging , 2011, Ageing Research Reviews.

[9]  C. Meisinger,et al.  Systemic inflammation (Interleukin 6) predicts all-cause mortality in men: results from a 9-year follow-up of the MEMO Study , 2011, AGE.

[10]  T. Lumley,et al.  Total and cause-specific mortality in the cardiovascular health study. , 2009, The journals of gerontology. Series A, Biological sciences and medical sciences.

[11]  L. Polito,et al.  Interleukin-6 plasma level increases with age in an Italian elderly population (“The Treviso Longeva”–Trelong–study) with a sex-specific contribution of rs1800795 polymorphism , 2009, AGE.

[12]  L. Ferrucci,et al.  Three‐Year Change in Inflammatory Markers in Elderly People and Mortality: The Invecchiare in Chianti Study , 2007, Journal of the American Geriatrics Society.

[13]  M. Jylhä,et al.  Interleukin-1 receptor antagonist, interleukin-6, and C-reactive protein as predictors of mortality in nonagenarians: the vitality 90+ study. , 2007, The journals of gerontology. Series A, Biological sciences and medical sciences.

[14]  D. Tanné,et al.  Interleukin-6 and the risk of future cardiovascular events in patients with angina pectoris and/or healed myocardial infarction. , 2006, The American journal of cardiology.

[15]  L. Ferrucci,et al.  Interleukin-6 in aging and chronic disease: a magnificent pathway. , 2006, The journals of gerontology. Series A, Biological sciences and medical sciences.

[16]  E. Steyerberg,et al.  Prediction of mortality risk in the elderly. , 2006, The American journal of medicine.

[17]  V. Salomaa,et al.  C-reactive protein, interleukin-6 and tumor necrosis factor alpha as predictors of incident coronary and cardiovascular events and total mortality , 2006, Thrombosis and Haemostasis.

[18]  D. Herrington,et al.  Effects of hormone therapyon C-reactive protein and IL-6 in postmenopausal women: a review article , 2005, Climacteric : the journal of the International Menopause Society.

[19]  V. Bykerk,et al.  Consensus Statement , 2004, Pediatric Clinical Practice Guidelines & Policies.

[20]  H. Cohen,et al.  Coagulation and activation of inflammatory pathways in the development of functional decline and mortality in the elderly. , 2003, The American journal of medicine.

[21]  L. Ferrucci,et al.  Peripheral Blood Markers of Inflammation Predict Mortality and Functional Decline in High‐Functioning Community‐Dwelling Older Persons , 2002, Journal of the American Geriatrics Society.

[22]  A. Siegbahn,et al.  Relationship between interleukin 6 and mortality in patients with unstable coronary artery disease: effects of an early invasive or noninvasive strategy. , 2001, JAMA.

[23]  L. Ferrucci,et al.  Cardiovascular Disease, Interleukin-6, and Risk of Mortality in Older Women: The Women’s Health and Aging Study , 2001, Circulation.

[24]  H. Cohen,et al.  Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. , 1999, The American journal of medicine.

[25]  G. Smith,et al.  Bias in meta-analysis detected by a simple, graphical test , 1997, BMJ.

[26]  C. Begg,et al.  Operating characteristics of a rank correlation test for publication bias. , 1994, Biometrics.

[27]  P. Tugwell,et al.  The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses , 2014 .

[28]  P. Georgiadou,et al.  Effect of hormone replacement therapy on inflammatory biomarkers. , 2009, Advances in clinical chemistry.

[29]  Evelyn Barron,et al.  This Work Is Licensed under a Creative Commons Attribution 4.0 International License Blood-borne Biomarkers of Mortality Risk: Systematic Review of Cohort Studies , 2022 .